Summary : This figure presents a clinical recommendation regarding weight loss for adults with overweight or obesity, specifically targeting blood pressure and hypertension management. table: Recommendation Overview : • Recommendation is for adults who have overweight or obesity. • Weight loss is recommended with a goal of at least 5% of body weight reduction. • The purpose is to prevent or treat elevated blood pressure (BP) and hypertension. Classification Codes : • COR (Class of Recommendation): 1 • LOE (Level of Evidence): A Reference Notes : • The recommendation is supported by references 1–9. Analysis : • The table provides a high-level, evidence-based clinical guideline emphasizing the importance of modest weight loss (≥5%) in managing or preventing high blood pressure in overweight or obese adults, with a strong recommendation (Class 1, Level A evidence).

This composite educational graphic details in vivo hemodynamic measurement techniques and results in the context of pulmonary arterial hypertension (PAH). Panel A presents an anatomical diagram of a heart, illustrating the positioning of a dual pressure sensor catheter inserted through the right ventricle into the main pulmonary artery (MPA), complemented by an ultrasonic flow probe wrapped around the MPA. Panel B displays three time-series hemodynamic graphs (0.0 to 0.20 seconds) comparing a placebo (PL) control group with four progressive stages of PAH (PAH1-PAH4). The top graph shows MPA blood pressure (mmHg), demonstrating a progressive increase in peak systolic pressure and steeper systolic slopes as disease severity increases. The middle graph depicts MPA flow (ml/min), showing relatively stable peak flow across stages but altered waveform morphology. The bottom graph shows right ventricular (RV) pressure (mmHg), highlighting a significant rise in RV systolic pressure (RVSP) from ~30 mmHg in PL/PAH1 to nearly 80 mmHg in stage PAH4, indicating increased ventricular afterload and disease progression.

This clinical photograph illustrates a patient-centered remote health monitoring setup for managing hypertension. The central focus is a digital oscillometric blood pressure monitor (A&D Medical UC-651BLE) displaying a systolic pressure of 133 mmHg, a diastolic pressure of 78 mmHg, and a pulse rate of 57 bpm. The device features a Bluetooth connectivity symbol, indicating its role in a wireless telemedicine ecosystem. A gray inflatable cuff is correctly placed on the patient's arm and connected to the base unit via tubing. In the adjacent hand, a smartphone displays a specialized medical application with a history of physiological readings, demonstrating the integration of mobile health (mHealth) technology in chronic disease management. This visual serves to teach the application of 'smart' diagnostic tools in home-based clinical processes, emphasizing data acquisition and real-time patient empowerment through digital tracking.

Summary : This flowchart outlines the diagnosis and treatment pathway for severe hypertension and hypertensive emergency, including decision points for acute target organ damage, specific crises (aortic dissection, pheochromocytoma), and recommended interventions based on clinical setting and severity. flowchart: # Nodes : • SBP >180 mm Hg or DBP >120 mm Hg (rectangle) • Acute target organ damage? (diamond) • Hypertensive emergency (rectangle) • Admit to ICU (rectangle, green COR 1) • Aortic dissection or Pheochromocytoma crisis? (diamond) • Aortic dissection: Reduce <120 mm Hg (rectangle, green COR 1) • Pheochromocytoma crisis: Reduce SBP <140 mm Hg in first hour (rectangle, green COR 1) • Severe hypertension (rectangle) • Identified in ED (rectangle) • Evaluate INP vs OPT treatment depending on indication(s) other than BP alone (rectangle) • Avoid parenteral BP lowering therapy or intensified oral therapy in the acute setting (rectangle, red COR 3-Harm) • Reduce SBP by 25% in the first hour and to 160/100-110 over the next 6 hours and to normal in the next 24-48 hours (rectangle, green COR 1) • Identified in OPT setting (rectangle) • No need to refer to ED. Reinstitute and intensify or modify medical therapy in the OPT setting (rectangle) • Close follow-up in the OPT setting in 4 weeks (rectangle) # Connectors : • SBP/DBP node flows to Acute target organ damage? (down arrow) • Acute target organ damage? YES → Hypertensive emergency; NO → Severe hypertension • Hypertensive emergency → Admit to ICU • Admit to ICU → Aortic dissection or Pheochromocytoma crisis? • Aortic dissection or Pheochromocytoma crisis? YES → Aortic dissection or Pheochromocytoma crisis nodes; NO → Reduce SBP by 25% node • Severe hypertension splits to Identified in ED and Identified in OPT setting • Identified in ED → Evaluate INP vs OPT treatment • Evaluate INP vs OPT treatment → Avoid parenteral BP lowering therapy (red X, avoid) • Identified in OPT setting → No need to refer to ED node • No need to refer to ED → Close follow-up in OPT setting in 4 weeks # Layout : • Top-down hierarchical flow, with major split at acute target organ damage. • Left branch for hypertensive emergency, right branch for severe hypertension. • Colour coding for class of recommendation (COR): green (1), yellow (2a), orange (2b), red (3-Harm). • Legend in top right corner for COR colour codes. # Analysis : • The flowchart provides a clear decision-making pathway for clinicians managing severe hypertension, distinguishing between hypertensive emergency (with organ damage) and severe hypertension (without organ damage). • Immediate ICU admission and aggressive BP reduction are recommended for emergencies, with specific targets for aortic dissection and pheochromocytoma crisis. • For severe hypertension, outpatient management and follow-up are emphasised, with a strong warning against inappropriate acute BP lowering in the absence of organ damage. • Colour coding highlights the strength and harm of recommendations, aiding rapid clinical decision-making.

<table><thead><tr><th>COR</th><th>LOE</th><th>RECOMMENDATIONS</th></tr></thead><tbody><tr><td>1</td><td>B-NR</td><td>1. In adults with a hypertensive emergency (BP >180 and/or >120 mm Hg and evidence of acute target organ damage), admission to an intensive care unit is recommended for continuous monitoring of BP and target organ damage and for consideration of parenteral administration of appropriate therapy (Tables 26 and 27, Figure 9).1-3</td></tr><tr><td>1</td><td>C-LD</td><td>2. For adults with a hypertensive emergency related to a compelling condition (eg, acute aortic syndrome or acute aortic dissection), SBP should be reduced to <140 mm Hg for most conditions and to <120 mm Hg in aortic dissection during the first hour, while monitoring for other target organ dysfunction.4-7</td></tr><tr><td>1</td><td>C-LD</td><td>3. For adults with a hypertensive emergency but without a compelling condition, SBP should be reduced with oral or parenteral therapy by no more than 25% within the first hour; then, if stable, to <160/100 mm Hg within the next 2 to 6 hours; and then cautiously to 130 to 140 mm Hg during the next 24 to 48 hours to limit target organ injury.2,8,9</td></tr><tr><td>3: Harm</td><td>B-NR</td><td>4. For adults with severe hypertension (>180/120 mm Hg) who are hospitalized for noncardiac conditions without evidence of acute target organ damage, intermittent use of additional IV or oral antihypertensive medications are not recommended to acutely reduce BP.8,10,11</td></tr></tbody></table>

This clinical photograph displays a retinal fundus image highlighting hypertension-mediated end-organ damage (EOD), specifically hypertensive retinopathy. The image is annotated with numerical markers indicating key diagnostic features: (1) points to blurred optic disc margins and papilloedema, signaling severe intracranial pressure or grade IV hypertensive changes; (2) identifies multiple cotton wool spots, which are small, fluffy, whitish lesions representing focal retinal ischemia; and (3) demonstrates generalized arteriolar attenuation and increased vascular tortuosity, where the retinal vessels appear narrowed and more winding than normal. The anatomical focus includes the optic nerve head, the retinal nerve fiber layer, and the retinal vasculature. This material is pedagogically relevant for ophthalmology and internal medicine, illustrating the ocular manifestations of malignant or accelerated hypertension and the importance of fundoscopic examination in assessing systemic cardiovascular risk and subclinical target organ damage.